Susquehanna International Group, LLP Amgen Inc Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $15 Million - $16.4 Million	-48,600 Reduced 3.44%	1,362,200 $439 Million
Q2 2024 Aug 15, 2024	BUY	$262.75 - $319.31 $79.7 Million - $96.8 Million	303,300 Added 27.39%	1,410,800 $441 Million
Q1 2024 May 07, 2024	SELL	$268.87 - $324.56 $39.8 Million - $48 Million	-147,900 Reduced 11.78%	1,107,500 $315 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $7.88 Million - $8.88 Million	30,800 Added 2.52%	1,255,400 $362 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $52.8 Million - $65.6 Million	241,500 Added 24.57%	1,224,600 $329 Million
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $39.6 Million - $46.8 Million	184,900 Added 23.16%	983,100 $218 Million
Q1 2023 May 16, 2023	BUY	$225.79 - $275.2 $12.5 Million - $15.2 Million	55,400 Added 7.46%	798,200 $193 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $49.8 Million - $63.2 Million	-217,300 Reduced 22.63%	742,800 $195 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $29.5 Million - $33.3 Million	-131,600 Reduced 12.05%	960,100 $216 Million

3,126

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $142B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.